Tirzepatide vs Semaglutide: Comparing Mounjaro and Ozempic for Weight Loss
Tirzepatide vs Semaglutide: Comparing Mounjaro and Ozempic for Weight Loss
By Dr. Onikepe Adegbola, MD PhD — Johns Hopkins-trained physician-scientist and founder of Casa de Sante
Key Takeaways
- Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 agonist; semaglutide (Ozempic/Wegovy) is GLP-1 only
- Head-to-head data: tirzepatide produces 5-7% MORE total body weight loss than semaglutide
- SURMOUNT trials showed up to 22.5% body weight loss with tirzepatide vs 15-17% with semaglutide in STEP trials
- GI side effects are similar for both — nausea, vomiting, diarrhea, constipation
- Both medications require nutritional support to prevent muscle loss, nutritional deficiency, and GI complications
How They Work Differently
Semaglutide (GLP-1 Receptor Agonist)
Mimics the natural GLP-1 hormone. Slows gastric emptying, increases insulin secretion, decreases glucagon, and acts on brain appetite centers to reduce hunger. Available as Ozempic (diabetes indication) and Wegovy (weight loss indication). Same molecule, different doses and branding.
Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)
Mimics BOTH GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) hormones. The addition of GIP receptor activation provides additional metabolic benefits: enhanced insulin secretion, improved fat metabolism, and possibly direct effects on adipose tissue. Available as Mounjaro (diabetes) and Zepbound (weight loss).
Weight Loss Comparison
| Metric | Semaglutide 2.4mg | Tirzepatide 15mg |
|---|---|---|
| Average weight loss | 15-17% | 20-22.5% |
| For a 250 lb person | ~37-42 lbs | ~50-56 lbs |
| Time to max effect | 68 weeks | 72 weeks |
| 5%+ weight loss achievers | 86% | 91% |
| 10%+ weight loss achievers | 69% | 79% |
Side Effect Comparison
GI side effects are the most common for both and are dose-dependent:
- Nausea: Semaglutide 44% vs Tirzepatide 31% (tirzepatide may cause less nausea)
- Diarrhea: Similar — 30% for both
- Constipation: Semaglutide 24% vs Tirzepatide 17%
- Vomiting: Similar — 24-25% for both
Most side effects are mild-to-moderate and decrease after 4-8 weeks at each dose level. The key management strategy is the same for both: slow dose escalation, small meals, adequate hydration, and digestive support.
Managing Side Effects for Both Medications
Nausea and Vomiting
- Small, frequent meals (4-6 per day)
- Avoid fatty, greasy foods
- Ginger tea or ginger chews
- Digestive enzymes with meals to accelerate food breakdown
Constipation
- Psyllium fiber (start low, increase gradually)
- Adequate water (64-80 oz daily)
- Walking 20+ minutes daily
- Casa de Sante Regularity Companion for gentle prokinetic support
Nutritional Deficiency Prevention
- Protein: 1.2-1.6g per kg daily. Casa de Sante Whey Protein shakes fill the gap when appetite is suppressed.
- Daily multivitamin to cover micronutrient gaps from reduced food intake
- Collagen peptides for skin, hair, and joint support during rapid weight loss
Which One Should You Choose?
Both are excellent medications. The choice often comes down to:
- Insurance coverage: Many insurers cover one but not the other
- Availability: Shortages have affected both at various times
- Weight loss goals: If you need more aggressive weight loss, tirzepatide has an edge
- Side effect tolerance: If nausea is your biggest concern, tirzepatide may cause slightly less
- Your prescriber's experience: Semaglutide has been available longer, so more prescribers are comfortable with it
🛒 Essential Support for Any GLP-1 Medication
- Digestive Enzymes — Manage nausea, bloating, and slow digestion on either medication
- Whey Protein — Prevent muscle loss with adequate protein when appetite is suppressed
- Collagen Peptides — Combat the skin, hair, and joint effects of rapid weight loss
- Regularity Companion — Address constipation without harsh stimulant laxatives
- Daily Vitamin — Fill nutritional gaps from eating less
Medical Disclaimer: This article is for educational purposes only. GLP-1 medications require a prescription. Discuss with your healthcare provider which medication is appropriate for you. Dr. Adegbola is the founder of Casa de Sante.
